Allen Investment Management LLC Nektar Therapeutics Transaction History

Allen Investment Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 06, 2019	SELL	$16.91 - $36.27 $361,231 - $774,799	-21,362 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$31.58 - $46.35 $674,611 - $990,128	21,362 New	21,362 $718,000
Q4 2018 Feb 05, 2019	SELL	$30.43 - $56.65 $706,189 - $1.31 Million	-23,207 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$57.4 - $108.44 $1.33 Million - $2.52 Million	23,207 New	23,207 $2.47 Million

140

135M

32.8K

55.5K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $244M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Allen Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Allen Investment Management LLC with notifications on news.